Laia Crespo
InvestorPartner at Sanofi Ventures
Paris, France
Writes $5M – $10M checks · typically $7.5M
About
Laia Crespo, a Cambridge PhD with chemistry training, sits on the boards of QurAlis, Therini Bio and Muna Therapeutics and architects new companies around neurodegeneration and genetic medicines.
Invests in
AI & Machine LearningBiotechData & InfrastructureHealthtechMedical Devices
Experience
- SanofiPartner - Sanofi Venturescurrent2018 — presentParis
- Ysios CapitalInvestment Director2015 — 2018
- Ysios CapitalInvestment Manager2009 — 2015Barcelona, Catalonia, Spain
- Johnson & JohnsonNew Business Development Analyst for Europe, Middle East and Africa2008 — 2009
- UCBResearch Scientist2007Cambridge, England, United Kingdom
- Medivir ABResearch Scientist2004 — 2007Cambridgeshire, England, United Kingdom
- Spirogen (now AstraZeneca)Research Scientist2002 — 2003London, England, United Kingdom
Education
- University of CambridgeMBA, Master in Business Administration
- Universitat de BarcelonaFirst Degree, MSc and PhD
- Liceu Music ConservatoireBachelors Degree, Piano and Music Theory
Same school
Also attended University of Cambridge621
Niko BonatsosInvestment Team at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesAnthony PhilippakisInvestor at GV (Google Ventures)Erik NordlanderInvestor at GV (Google Ventures)Nic LowdenInvestor at Moonfire Ventures
+ 615 more
Also attended Universitat de Barcelona88
Andrea AmadorCompliance Manager at Inveready Technology Investment GroupNelson CardonaController at Inveready Technology Investment GroupJosep Maria EcharriManaging Partner & CEO at Inveready Technology Investment GroupMar FernándezMarketing & Communications Manager at Inveready Technology Investment GroupMartina MilàAnalyst at Inveready Technology Investment GroupSara SecallGeneral Partner at Inveready Technology Investment Group
+ 82 more
Shared employers
Also worked at Ysios Capital16
Josep Ll. SanfeliuCo-founder and managing partner at Asabys PartnersSylvain SachotPartner at Asabys PartnersIsabel JimenezPrincipal at Asabys PartnersJulia SalaverríaManaging Partner at Ysios CapitalKaren WagnerManaging Partner at Ysios CapitalCristina GarmendiaGeneral Partner at Ysios Capital
+ 10 more
Also worked at Johnson & Johnson128
Karthik ArdhanareeswaranInvestor at GV (Google Ventures)KobeFinance Director at Hummingbird VenturesMickelFinance & Risk Management at Hummingbird VenturesHal PazInvestor at Khosla VenturesAaron PriceCEO, TechUnited at Tech Council VenturesJung Lee, PhDVenture Partner at Adelphi Ventures Management, Llc
+ 122 more
Also worked at UCB13
Stephen RapeckiInvestor at MedicxiMiguel ForteAdvisor at Delin VenturesCaroline GoddeerisPartner at Fund+Claire BrownPartner at Oxford Science EnterprisesLeen LimbourgInvestment Manager at Meusinvest (Noshaq)George SyrmalisDr at Bioscience Equity Partners
+ 7 more
Also worked at Medivir AB1
Colleagues at Sanofi Ventures
Anne
Investor at Sanofi Ventures
Anne Jammal
Executive Assistant at Sanofi Ventures
Becca
Investor at Sanofi Ventures
Camille Ridel
Investor at Sanofi Ventures
Chris
Investor at Sanofi Ventures
Christopher Gagliardi
Principal at Sanofi Ventures
Cris
Partner at Sanofi Ventures
Cris De Luca
Partner, Digital at Sanofi Ventures
Network4
Camille Ridel
Investor at Sanofi Ventures
Carole Nuechterlein
Head of Roche Venture Fund at Roche Venture Fund
Christopher Gagliardi
Principal at Sanofi Ventures
Cris De Luca
Partner, Digital at Sanofi Ventures
Investors connected to Laia in public investor directories — a warm-intro map.

.png)






























